{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:36:22Z","timestamp":1790861782893,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T00:00:00Z","timestamp":1212451200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Non-steroidal anti-inflammatory drugs (NSAIDs) are recommended for multimodal postoperative pain management. We evaluated opioid-sparing effects and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a prospective, randomized, observer-blind control study. Eighty patients that underwent total knee arthroplasty were randomized into two groups of 40 each. The study group received a single 400 mg dose of celecoxib, one hour before surgery, and 200 mg of celecoxib every 12 hours for five days, along with patient-controlled analgesic (PCA) morphine. The control group received only PCA morphine for postoperative pain management. Visual analog scale (VAS) pain scores, active range of motion (ROM), total opioid use and postoperative nausea\/vomiting were analyzed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Groups were comparable for age, pre-operative ROM, operation duration and intraoperative blood loss. Resting VAS pain scores improved significantly in the celecoxib group, compared with controls, at 48 hrs (2.13 \u00b1 1.68 vs. 3.43 \u00b1 1.50, p = 0.03) and 72 hrs (1.78 \u00b1 1.66 vs. 3.17 \u00b1 2.01, p = 0.02) after surgery. Active ROM also increased significantly in the patients that received celecoxib, especially in the first 72 hrs [40.8\u00b0 \u00b1 17.3\u00b0 vs. 25.8\u00b0 \u00b1 11.5\u00b0, p = 0.01 (day 1); 60.7\u00b0 \u00b1 18.1\u00b0 vs. 45.0\u00b0 \u00b1 17.3\u00b0, p = 0.004 (day 2); 77.7\u00b0 \u00b1 15.1\u00b0 vs. 64.3\u00b0 \u00b1 16.9\u00b0, p = 0.004 (day 3)]. Opioid requirements decreased about 40% (p = 0.03) in the celecoxib group. Although patients suffering from post-operative nausea\/vomiting decreased from 43% in control group to 28% in celecoxib group, this was not significant (p = 0.57). There were no differences in blood loss (intra- and postoperative) between the groups. Celecoxib resulted in no significant increase in the need for blood transfusions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Perioperative celecoxib significantly improved postoperative resting pain scores at 48 and 72 hrs, opioid consumption, and active ROM in the first three days after total knee arthroplasty, without increasing the risks of bleeding.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Clinicaltrials.gov NCT00598234<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2474-9-77","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T06:15:00Z","timestamp":1212473700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Perioperative celecoxib administration for pain management after total knee arthroplasty \u2013 A randomized, controlled study"],"prefix":"10.1186","volume":"9","author":[{"given":"Yu-Min","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiu-Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Ti","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Peng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lih-Ching","family":"Horng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,3]]},"reference":[{"issue":"6827","key":"483_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/35068566","volume":"410","author":"TA Samad","year":"2001","unstructured":"Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ: Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature. 2001, 410 (6827): 471-475. 10.1038\/35068566.","journal-title":"Nature"},{"issue":"1","key":"483_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0304-3959(94)90045-0","volume":"59","author":"K McCormack","year":"1994","unstructured":"McCormack K: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain. 1994, 59 (1): 9-43. 10.1016\/0304-3959(94)90045-0.","journal-title":"Pain"},{"issue":"2","key":"483_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/bja\/88.2.199","volume":"88","author":"M Hyllested","year":"2002","unstructured":"Hyllested M, Jones S, Pedersen JL, Kehlet H: Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review. British journal of anaesthesia. 2002, 88 (2): 199-214. 10.1093\/bja\/88.2.199.","journal-title":"British journal of anaesthesia"},{"issue":"5","key":"483_CR4","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.0001-5172.2004.00379.x","volume":"48","author":"J Romsing","year":"2004","unstructured":"Romsing J, Moiniche S: A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Acta anaesthesiologica Scandinavica. 2004, 48 (5): 525-546. 10.1111\/j.0001-5172.2004.00379.x.","journal-title":"Acta anaesthesiologica Scandinavica"},{"issue":"6","key":"483_CR5","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1097\/00000542-200512000-00025","volume":"103","author":"N Elia","year":"2005","unstructured":"Elia N, Lysakowski C, Tramer MR: Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials. Anesthesiology. 2005, 103 (6): 1296-1304. 10.1097\/00000542-200512000-00025.","journal-title":"Anesthesiology"},{"issue":"5","key":"483_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1399-6576.2005.00666.x","volume":"49","author":"S Straube","year":"2005","unstructured":"Straube S, Derry S, McQuay HJ, Moore RA: Effect of preoperative Cox-II-selective NSAIDs (coxibs) on postoperative outcomes: a systematic review of randomized studies. Acta anaesthesiologica Scandinavica. 2005, 49 (5): 601-613. 10.1111\/j.1399-6576.2005.00666.x.","journal-title":"Acta anaesthesiologica Scandinavica"},{"issue":"6","key":"483_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/00000542-200506000-00027","volume":"102","author":"E Marret","year":"2005","unstructured":"Marret E, Kurdi O, Zufferey P, Bonnet F: Effects of nonsteroidal antiinflammatory drugs on patient-controlled analgesia morphine side effects: meta-analysis of randomized controlled trials. Anesthesiology. 2005, 102 (6): 1249-1260. 10.1097\/00000542-200506000-00027.","journal-title":"Anesthesiology"},{"issue":"2","key":"483_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0952-8180(01)00219-7","volume":"13","author":"JJ Huang","year":"2001","unstructured":"Huang JJ, Taguchi A, Hsu H, Andriole GL, Kurz A: Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: a prospective, randomized, double-blinded, placebo-controlled trial. J Clin Anesth. 2001, 13 (2): 94-97. 10.1016\/S0952-8180(01)00219-7.","journal-title":"J Clin Anesth"},{"issue":"3","key":"483_CR9","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/00000542-200203000-00032","volume":"96","author":"S Moiniche","year":"2002","unstructured":"Moiniche S, Kehlet H, Dahl JB: A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology. 2002, 96 (3): 725-741. 10.1097\/00000542-200203000-00032.","journal-title":"Anesthesiology"},{"issue":"5","key":"483_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/BF03021054","volume":"50","author":"ML Bugter","year":"2003","unstructured":"Bugter ML, Dirksen R, Jhamandas K, Slappendel R, Weber EW, Milne B: Prior ibuprofen exposure does not augment opioid drug potency or modify opioid requirements for pain inhibition in total hip surgery. Can J Anaesth. 2003, 50 (5): 445-449.","journal-title":"Can J Anaesth"},{"issue":"1","key":"483_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00000539-200201000-00010","volume":"94","author":"SS Reuben","year":"2002","unstructured":"Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J: The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesthesia and analgesia. 2002, 94 (1): 55-59. 10.1097\/00000539-200201000-00010. table of contents","journal-title":"Anesthesia and analgesia"},{"issue":"5","key":"483_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1097\/00000539-200011000-00032","volume":"91","author":"SS Reuben","year":"2000","unstructured":"Reuben SS, Connelly NR: Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesthesia and analgesia. 2000, 91 (5): 1221-1225. 10.1097\/00000539-200011000-00032.","journal-title":"Anesthesia and analgesia"},{"issue":"1","key":"483_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1054\/arth.2002.27677","volume":"17","author":"SS Reuben","year":"2002","unstructured":"Reuben SS, Fingeroth R, Krushell R, Maciolek H: Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty. 2002, 17 (1): 26-31. 10.1054\/arth.2002.27677.","journal-title":"J Arthroplasty"},{"issue":"18","key":"483_CR14","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.290.18.2411","volume":"290","author":"A Buvanendran","year":"2003","unstructured":"Buvanendran A, Kroin JS, Tuman KJ, Lubenow TR, Elmofty D, Moric M, Rosenberg AG: Effects of perioperative administration of a selective cyclooxygenase 2 inhibitor on pain management and recovery of function after knee replacement: a randomized controlled trial. Jama. 2003, 290 (18): 2411-2418. 10.1001\/jama.290.18.2411.","journal-title":"Jama"},{"issue":"4","key":"483_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1213\/ane.0b013e318165e208","volume":"106","author":"SS Reuben","year":"2008","unstructured":"Reuben SS, Buvenandran A, Katz B, Kroin JS: A prospective randomized trial on the role of perioperative celecoxib administration for total knee arthroplasty: improving clinical outcomes. Anesth Analg. 2008, 106 (4): 1258-1264. table of contents","journal-title":"Anesth Analg"},{"issue":"4","key":"483_CR16","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2165\/00003495-200059040-00017","volume":"59","author":"D Clemett","year":"2000","unstructured":"Clemett D, Goa KL: Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drugs. 2000, 59 (4): 957-980. 10.2165\/00003495-200059040-00017.","journal-title":"Drugs"},{"issue":"6","key":"483_CR17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1097\/00000542-200306000-00030","volume":"98","author":"E Marret","year":"2003","unstructured":"Marret E, Flahault A, Samama CM, Bonnet F: Effects of postoperative, nonsteroidal, antiinflammatory drugs on bleeding risk after tonsillectomy: meta-analysis of randomized, controlled trials. Anesthesiology. 2003, 98 (6): 1497-1502. 10.1097\/00000542-200306000-00030.","journal-title":"Anesthesiology"},{"issue":"2","key":"483_CR18","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/clpt.1983.159","volume":"34","author":"K Sriwatanakul","year":"1983","unstructured":"Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G: Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther. 1983, 34 (2): 234-239.","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"483_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/emj.18.3.205","volume":"18","author":"AM Kelly","year":"2001","unstructured":"Kelly AM: The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001, 18 (3): 205-207. 10.1136\/emj.18.3.205.","journal-title":"Emerg Med J"},{"issue":"1","key":"483_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2253-2-4","volume":"2","author":"J Barden","year":"2002","unstructured":"Barden J, Edwards JE, McQuay HJ, Moore RA: Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review. BMC Anesthesiol. 2002, 2 (1): 4-10.1186\/1471-2253-2-4.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"483_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2253-3-1","volume":"3","author":"J Barden","year":"2003","unstructured":"Barden J, Edwards JE, McQuay HJ, Moore RA: Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review. BMC Anesthesiol. 2003, 3 (1): 1-10.1186\/1471-2253-3-1.","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"483_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2253-4-3","volume":"4","author":"JE Edwards","year":"2004","unstructured":"Edwards JE, Moore RA, McQuay HJ: Individual patient meta-analysis of single-dose rofecoxib in postoperative pain. BMC Anesthesiol. 2004, 4 (1): 3-10.1186\/1471-2253-4-3.","journal-title":"BMC Anesthesiol"},{"key":"483_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2106\/JBJS.D.02283","volume":"87","author":"SS Reuben","year":"2005","unstructured":"Reuben SS, Ekman EF: The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. The Journal of bone and joint surgery. 2005, 87: 536-542. 10.2106\/JBJS.D.02283.","journal-title":"The Journal of bone and joint surgery"},{"issue":"2","key":"483_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1399-6576.2005.00614.x","volume":"49","author":"J Romsing","year":"2005","unstructured":"Romsing J, Moiniche S, Mathiesen O, Dahl JB: Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation: a systematic review. Acta anaesthesiologica Scandinavica. 2005, 49 (2): 133-142. 10.1111\/j.1399-6576.2005.00614.x.","journal-title":"Acta anaesthesiologica Scandinavica"},{"issue":"1","key":"483_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bja\/75.1.15","volume":"75","author":"JE Rogers","year":"1995","unstructured":"Rogers JE, Fleming BG, Macintosh KC, Johnston B, Morgan-Hughes JO: Effect of timing of ketorolac administration on patient-controlled opioid use. British journal of anaesthesia. 1995, 75 (1): 15-18.","journal-title":"British journal of anaesthesia"},{"issue":"8","key":"483_CR26","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1016\/0006-2952(94)90205-4","volume":"48","author":"T Klein","year":"1994","unstructured":"Klein T, Nusing RM, Pfeilschifter J, Ullrich V: Selective inhibition of cyclooxygenase 2. Biochem Pharmacol. 1994, 48 (8): 1605-1610. 10.1016\/0006-2952(94)90205-4.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"483_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/sj.bjp.0701076","volume":"121","author":"D Riendeau","year":"1997","unstructured":"Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Leger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Therien M, Wang Z, Webb JK, Wong E, Chan CC: Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997, 121 (1): 105-117. 10.1038\/sj.bjp.0701076.","journal-title":"Br J Pharmacol"},{"issue":"21","key":"483_CR28","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","volume":"343","author":"C Bombardier","year":"2000","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000, 343 (21): 1520-1528. 10.1056\/NEJM200011233432103. 1522 p following 1528","journal-title":"N Engl J Med"},{"issue":"10","key":"483_CR29","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","volume":"284","author":"FE Silverstein","year":"2000","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefowith JB, Verburg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Jama. 2000, 284 (10): 1247-1255. 10.1001\/jama.284.10.1247.","journal-title":"Jama"},{"issue":"11","key":"483_CR30","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1056\/NEJMoa050405","volume":"352","author":"SD Solomon","year":"2005","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005, 352 (11): 1071-1080. 10.1056\/NEJMoa050405.","journal-title":"N Engl J Med"},{"issue":"1","key":"483_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.amjcard.2006.07.069","volume":"99","author":"WB White","year":"2007","unstructured":"White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM: Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol. 2007, 99 (1): 91-98. 10.1016\/j.amjcard.2006.07.069.","journal-title":"Am J Cardiol"},{"key":"483_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1471-2474-8-73","volume":"8","author":"RA Moore","year":"2007","unstructured":"Moore RA, Derry S, McQuay HJ: Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk. BMC Musculoskelet Disord. 2007, 8: 73-10.1186\/1471-2474-8-73.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7553","key":"483_CR33","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","volume":"332","author":"PM Kearney","year":"2006","unstructured":"Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ (Clinical research ed). 2006, 332 (7553): 1302-1308. 10.1136\/bmj.332.7553.1302.","journal-title":"BMJ (Clinical research ed)"},{"issue":"2","key":"483_CR34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1177\/00912700022008766","volume":"40","author":"PT Leese","year":"2000","unstructured":"Leese PT, Hubbard RC, Karim A, Isakson PC, Yu SS, Geis GS: Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial. Journal of clinical pharmacology. 2000, 40 (2): 124-132. 10.1177\/00912700022008766.","journal-title":"Journal of clinical pharmacology"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-9-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-9-77\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-9-77","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-9-77.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:58:20Z","timestamp":1630457900000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-9-77"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,3]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["483"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-9-77","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,3]]},"assertion":[{"value":"17 December 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}